224 related articles for article (PubMed ID: 31270249)
1. Association between PTEN and clinical-pathological features of osteosarcoma.
Zhou J; Xiao X; Wang W; Luo Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31270249
[TBL] [Abstract][Full Text] [Related]
2. The prognostic role of CD133 expression in patients with osteosarcoma.
Xu N; Kang Y; Wang W; Zhou J
Clin Exp Med; 2020 May; 20(2):261-267. PubMed ID: 32048073
[TBL] [Abstract][Full Text] [Related]
3. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.
Zhang Y; Ding C; Wang J; Sun G; Cao Y; Xu L; Zhou L; Chen X
J Orthop Surg Res; 2015 Dec; 10():187. PubMed ID: 26697855
[TBL] [Abstract][Full Text] [Related]
5. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
[TBL] [Abstract][Full Text] [Related]
6. HER-2 expression in biopsy and surgical specimen on prognosis of osteosarcoma: A systematic review and meta-analysis of 16 studies.
Zhang Q; Liu F; Wang B; Li Z; Zhou D; Yang Q; Dong J; Li J
Medicine (Baltimore); 2016 Jun; 95(23):e3661. PubMed ID: 27281068
[TBL] [Abstract][Full Text] [Related]
7. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression.
Yuan H; Gao Y
Oncol Rep; 2015 Nov; 34(5):2706-14. PubMed ID: 26328886
[TBL] [Abstract][Full Text] [Related]
9. MiR-19a as a prognostic indicator for cancer patients: a meta-analysis.
Peng Y; Huang D; Ma K; Deng X; Shao Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015372
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value and potential drug target of phosphatase and tensin homolog in breast cancer patients: A meta-analysis.
Xu F; Zhang C; Cui J; Liu J; Li J; Jiang H
Medicine (Baltimore); 2017 Sep; 96(36):e8000. PubMed ID: 28885360
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN.
Chen J; Yan D; Wu W; Zhu J; Ye W; Shu Q
Oncol Rep; 2016 Jun; 35(6):3285-92. PubMed ID: 27035216
[TBL] [Abstract][Full Text] [Related]
12. Effect of the PTEN gene on adhesion, invasion and metastasis of osteosarcoma cells.
Hu Y; Xu S; Jin W; Yi Q; Wei W
Oncol Rep; 2014 Oct; 32(4):1741-7. PubMed ID: 25069680
[TBL] [Abstract][Full Text] [Related]
13. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.
Zhang W; Ren X; Qi L; Zhang C; Tu C; Li Z
BMC Cancer; 2021 Feb; 21(1):202. PubMed ID: 33639865
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis.
Luo D; Ren H; Zhang W; Xian H; Lian K; Liu H
J Orthop Surg Res; 2019 Feb; 14(1):56. PubMed ID: 30782196
[TBL] [Abstract][Full Text] [Related]
15. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
16. Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors.
Freeman SS; Allen SW; Ganti R; Wu J; Ma J; Su X; Neale G; Dome JS; Daw NC; Khoury JD
Cancer; 2008 Sep; 113(6):1453-61. PubMed ID: 18704985
[TBL] [Abstract][Full Text] [Related]
17. PTEN in kidney cancer: A review and meta-analysis.
Que WC; Qiu HQ; Cheng Y; Liu MB; Wu CY
Clin Chim Acta; 2018 May; 480():92-98. PubMed ID: 29408173
[TBL] [Abstract][Full Text] [Related]
18. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
[TBL] [Abstract][Full Text] [Related]
19. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.
Qu JT; Wang M; He HL; Tang Y; Ye XJ
J Cancer Res Clin Oncol; 2012 May; 138(5):819-25. PubMed ID: 22274866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
